Initial treatment of well-differentiated neuroendocrine tumors

Oncology (Williston Park). 2014 Nov;28(11):945-7.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Differentiation*
  • Combined Modality Therapy
  • Humans
  • Neuroendocrine Tumors / drug therapy*
  • Neuroendocrine Tumors / pathology
  • Neuroendocrine Tumors / surgery*
  • Prognosis

Substances

  • Antineoplastic Agents